中金:上調安踏(2020.HK)目標價至94.64港元 評級“優於大市”
中金髮表研究報告指,安踏體育(2020.HK)旗下安踏及FILA品牌的銷售在三季度增長顯示出韌性,而其他子品牌亦具潛力,遂維持“優於大市”的投資評級,並上調目標價約26%至94.64港元。
中金指,安踏將全年銷售目標定在10億元人民幣,其線上銷售增速加快,渠道庫存週期及零售折扣維持在相對健康的水平。儘管基數較高,但FILA品牌銷售仍穩健成長。此外,Descente品牌在其他子品牌中表現最好。
中金又認為,香港零售環境料對公司影響有限,因香港在FILA銷售佔比僅有大約5%,在集團層面的影響更小。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.